• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Molecular Therapy-Nucleic Acids

    Molecular Therapy-Nucleic Acids

    JournalISSN 2162-2531eISSN 2162-2531中科院 医学 2区

    年发文量

    研究主题

    论文(3478)

    排序
    1From Self-Amplification to Engineered Replication: Designing Next-Generation Sarna Platforms
    Jimi Kim
    2026
    引用
    AI阅读
    加入学术空间
    2Nucleic Acid Therapeutics for Treating Glioblastoma: from Modality and Delivery Design to Scalable Nanomedicine Platforms
    Fatima Hameedat, Alma Balleh, Arjen Zijlstra, Sara Nogueira, Cesare Di Nitto, Dominik Witzigmann,Flávia Sousa
    2026
    引用
    AI阅读
    加入学术空间
    3Hyaluronan Accumulation Mediated by Human Identical Sequences Provides a Broad-Spectrum Therapeutic Strategy Against Virulent Coronaviruses
    Jin Wu, Zichen Song, Hongyan Wei, Yuxiao Jin,Dezhuan Da, Lu Chen,Mengxing Liu, Yi Miu, Zheng,Shuai Yang,Wenqiang Yu
    2026
    引用
    AI阅读
    加入学术空间
    4Fatty-acid-based Antimir-23B Allows Brain Delivery and Reverses DM1 CNS Defects in DMSXL Mice
    Diego Piqueras-Losilla,Geneviève Gourdon,Ruben Artero,Beatriz Llamusí,Estefanía Cerro-Herreros

    Myotonic dystrophy type 1 (DM1) is a multisystemic disorder caused by the expansion of CTG repeats in the 3′ untranslated region of DMPK. Although skeletal muscle and cardiac manifestations are among the most recognized features of the disease, DM1 also affects the central nervous system (CNS) and impacts significantly patients’ quality of life, with manifestations ranging from cognitive and behavioral abnormalities to sleep disturbances and, in the congenital form of the disease (CDM), severe neurodevelopmental impairment.

    2026
    引用
    AI阅读
    加入学术空间
    5Combination of Live-Attenuated and Adenovirus-Based Vaccines Provides Immediate and Durable Protection Against Yersinia Pestis in Mice
    Emily K. Hendrix,Jian Sha,Paul B. Kilgore,Blake H. Neil,Atul K. Verma, Edwin B. Rodriguez,Ashok K. Chopra

    Yersinia pestis is the etiological agent of pandemic-causing plague with no Food and Drug Administration (FDA) approved vaccines. The natural emergence or intentional release of antimicrobial-resistant strains are alarming, necessitating development of new-generation vaccines and immunization strategies that produce rapid and durable immunity. Herein, we evaluated immediate (within 7 days) or longterm (6 months) protection and immune responses combining patented live-attenuated vaccines (LAVs) with trivalent adenovirus-type 5-based vaccine (Ad5-YFV) C57BL/6 mice. Animals were immunized with either a two dose prime-pull strategy (intramuscular [i.m.] injection LAVs followed by intranasal [i.n.] instillation of Ad5-YFV, 21 days apart) or a 1-dose strategy by simultaneous administration of LAVs (i.m.) and Ad5-YFV (i.n.). Animals immunized with both strategies were either challenged after 6 months or, with the simultaneous strategy, 7 days post-vaccination in lethal pneumonic or bubonic Y. pestis CO92 infection models. Mice immunized with both strategies were completely protected and elicited robust and durable humoral and cellular immune responses through 6 months. Simultaneous vaccination also protected animals against bubonic (100%) and pneumonic (80%) challenges 7 days post-vaccination with rapid induction of immunoglobulin M (IgM), IgG3, and total IgG humoral responses. Thus, these vaccines and strategies are suitable for reactive (emergency) and preventive (in endemic regions) use.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3478 篇论文

    高被引作者

    作者引用发文
    Xiaohui Zhang18832
    Tee Louis Y18821
    QunShan Huang18821
    Shihua Yang18821
    Pieter R. Cullis13376
    Ying Tam12689
    Paulo J C Lin12114
    Hao Lin11749
    Kuo-Chen Chou11235
    Chen Sam10503

    高产作者

    作者引用发文
    Matthew Wood83721
    John J. Rossi67421
    Chiranjib Chakraborty100320
    Khvorova Anastasia49219
    Manojit Bhattacharya28218
    Paloma H Giangrande17416
    Yixue Xue54214
    Aurelie Goyenvalle18513
    Maxim V Berezovski28213
    Annemieke Aartsma-Rus29112

    相关期刊

    Cell and Bioscience
    Clinical and translational medicine
    Cell death discovery
    Trends in Cell Biology
    Cell Death and Differentiation
    Molecular Therapy
    Experimental and Molecular Medicine
    Cell Communication and Signaling
    Cellular Signalling
    Experimental Cell Research